TransCyte

07/01/2000 - "Safety and efficacy of TransCyte for the treatment of partial-thickness burns."
07/01/1999 - "Safety and efficacy of TransCyte for the treatment of partial-thickness burns."
11/01/2006 - "To date, this is the largest study to determine if Transcyte reduces LOS for partial thickness burns of any size or etiology. "
08/01/2004 - "Treatment of partial-thickness burns: a prospective, randomized trial using Transcyte."
08/01/2001 - "There was no difference in the type of burns in each group, the majority were liquid scald type, 70% in the standard therapy group versus 90% in the TransCyte group. "

10/01/2000 - "Full-thickness wounds were excised as early as patient condition permitted, and wounds were closed with autograft, allograft, or TransCyte (Advanced Tissue Sciences Inc., La Jolla, CA). "
07/01/1999 - "Wounds treated with TransCyte healed more quickly (mean 11.14 days to 90% epithelialization vs 18.14 days, P = .002). "
01/01/1997 - "A histological study of Dermagraft-TC in patients' burn wounds."
08/01/2001 - "All pediatric burns greater than 7% total body surface area (TBSA) that occurred after October 1999 underwent wound closure with TransCyte (n = 20). "
07/01/1999 - "There were no infections in the 32 wound sites treated with TransCyte. "

07/01/1999 - "There were no infections in the 32 wound sites treated with TransCyte. "

02/01/2002 - "The authors highlight processes and outcomes of some of the organization's surgical pathways, including guidelines for children with second degree burns grafted with TransCyte, those children hospitalized for tonsillectomy or adenoidectomy, appendectomies, atrial and ventricular septal defects, and percutaneous endoscopic gastrostomy or surgical gastrostomy procedures."

07/01/1999 - "The results indicated that wound sites treated with TransCyte healed with less hypertrophic scarring than sites treated with silver sulfadiazine (P < .001 at 3 and 6 months, P = .006 at 12 months)."